Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Oct 2022. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5147027012 | Product containing precisely chlorhexidine gluconate 500 microgram/1 milliliter and tetracaine 150 microgram/1 milliliter conventional release oromucosal spray (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 5147028019 | Chlorhexidine gluconate 500 microgram/mL and tetracaine 150 microgram/mL oromucosal spray | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely chlorhexidine gluconate 500 microgram/1 milliliter and tetracaine 150 microgram/1 milliliter conventional release oromucosal spray (clinical drug) | Is a | Product containing only chlorhexidine and tetracaine in oromucosal dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely chlorhexidine gluconate 500 microgram/1 milliliter and tetracaine 150 microgram/1 milliliter conventional release oromucosal spray (clinical drug) | Has manufactured dose form | Conventional release oromucosal spray | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely chlorhexidine gluconate 500 microgram/1 milliliter and tetracaine 150 microgram/1 milliliter conventional release oromucosal spray (clinical drug) | Has precise active ingredient | Chlorhexidine gluconate | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely chlorhexidine gluconate 500 microgram/1 milliliter and tetracaine 150 microgram/1 milliliter conventional release oromucosal spray (clinical drug) | Has basis of strength substance | Chlorhexidine gluconate | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely chlorhexidine gluconate 500 microgram/1 milliliter and tetracaine 150 microgram/1 milliliter conventional release oromucosal spray (clinical drug) | Has concentration strength numerator unit | microgram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely chlorhexidine gluconate 500 microgram/1 milliliter and tetracaine 150 microgram/1 milliliter conventional release oromucosal spray (clinical drug) | Has concentration strength denominator unit | Milliliter | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely chlorhexidine gluconate 500 microgram/1 milliliter and tetracaine 150 microgram/1 milliliter conventional release oromucosal spray (clinical drug) | Has precise active ingredient | Tetracaine | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely chlorhexidine gluconate 500 microgram/1 milliliter and tetracaine 150 microgram/1 milliliter conventional release oromucosal spray (clinical drug) | Has basis of strength substance | Tetracaine | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely chlorhexidine gluconate 500 microgram/1 milliliter and tetracaine 150 microgram/1 milliliter conventional release oromucosal spray (clinical drug) | Has concentration strength numerator unit | microgram | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely chlorhexidine gluconate 500 microgram/1 milliliter and tetracaine 150 microgram/1 milliliter conventional release oromucosal spray (clinical drug) | Has concentration strength denominator unit | Milliliter | true | Inferred relationship | Existential restriction modifier | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR